Affordable Access

deepdyve-link
Publisher Website

Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study.

Authors
  • Călugăru, Dan
  • Călugăru, Mihai
Type
Published Article
Journal
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Publication Date
Mar 01, 2015
Volume
31
Issue
2
Pages
78–86
Identifiers
DOI: 10.1089/jop.2014.0037
PMID: 25313921
Source
Medline
License
Unknown

Abstract

The 3-year IVB therapy provided sustained vision and FT gains in most phakic patients with acute C/HCRVOs, making this treatment option a rational and viable therapeutic strategy. Bevacizumab was more effective in patients with ischemic occlusions who required a significantly higher number of injections.

Report this publication

Statistics

Seen <100 times